Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lang, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lang, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 122, No. 1, 3-4, January 1999
© 1999 Oxford University Press

Editorial

Another autoantibody in paraneoplastic neurological disease

Bethan Lang

Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK

Paraneoplastic neurological syndromes (PNS) are an uncommon group of disorders caused by immune responses primarily directed against an underlying neoplasm that cross-react with proteins expressed in the peripheral or central nervous system. Understanding the relationship between expression of specific proteins in the tumour and the autoimmune neurological disease with which they associate is an ongoing challenge.

PNS are frequently associated with the presence of specific serum autoantibodies, which may be used as a diagnostic aid. For example, anti-Hu (also called anti-neuronal nuclear antibody 1, ANNA-1) is an antibody detected in the sera of patients with . . . [Full Text of this Article]

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BrainHome page
C. J. A. De Groot, E. Bergers, W. Kamphorst, R. Ravid, C. H. Polman, F. Barkhof, and P. van der Valk
Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: Increased yield of active demyelinating and (p)reactive lesions
Brain, August 1, 2001; 124(8): 1635 - 1645.
[Abstract] [Full Text] [PDF]